Skip to content

Interventional symptomatic treatment of knee osteoarthritis using ablation of the nerves surrounding the knee joint

Classic vs New Anatomical Targets for Cooled Radiofrequency Ablation of the Genicular Nerves in the Symptomatic Management of Knee Osteoarthritis: A Prospective, Randomized, Double-Blind Clinical Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN84066069
Enrollment
200
Registered
2026-06-15
Start date
2025-09-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Moderated osteoarthritis of the knee joint Musculoskeletal Diseases

Interventions

Patients will be placed on the radiolucent table at the Department of Interventional Radiology in a supine position with a bolster under the knee to produce 30? of flexion
this position flattens the suprapatellar joint space, thus minimizing needle trespass, and also allows for an unobstructed lateral view of the knee. The treated knee will be draped and sterilized in a

Sponsors

University of Patras
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 90 Years

Inclusion criteria

Inclusion criteria: Patients of either sex will participate in the clinical trial as long as they have: 1. The NICE clinical criteria of primary knee OA for one or both knees: 1.1. Age >45 years 1.2. Activity-related joint pain 1.3. No morning joint stiffness or morning stiffness that lasts no longer than 30 minutes 2. Radiological confirmation of knee arthritis (grade =2) according to the Kellgren and Lawrence classification 3. Chronic knee pain for a minimum duration of 6 months 4. Pain intensity =4 on the (NRPS) 5. Lack of pain relief from conventional therapy, including nonsteroidal anti-inflammatory drugs (NSAIDs), opioids, muscle relaxants, oral steroids, physical therapy, and intra-articular injection therapy. 6. The ability to communicate in Greek

Exclusion criteria

Exclusion criteria: 1. inflammatory or post-traumatic knee arthritis 2. Patients who have received CRFA treatment in the past 3. Injection of hyaluronic acid or corticosteroid within the previous 3 months 4. Significant structural deformities affecting locomotion and knee function aside from osteoarthritis and which might cause chronic knee pain 5. Body mass index =40 kg/m² 6. Uncontrolled serious disease (cancer, diabetes, end-stage heart disease etc) 7. Unstable psychiatric illness 8. Coagulopathy or bleeding disorders 9. Active systemic or local infection

Design outcomes

Primary

MeasureTime frame
Pain associated with knee OA measured using the Numerical Rating Pain Scale (NRPS) at 1, 3, and 6-month post-intervention

Secondary

MeasureTime frame
Safety and tolerability of the interventions, and patient’s clinical outcome measured using the Knee Injury and Osteoarthritis Outcome Score for Joint Replacement (KOOS-JR), the Oxford Knee Score (OKS), the SF-12 and the Forgotten Joint Score (FJS) at 1-, 3- and 6-months post-intervention

Countries

Greece

Contacts

Public ContactAndreas Panagopoulos
anpanagop@med.upatras.gr+306944363624

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Jul 3, 2026